Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Kidney disease therapies investigated in cat study
"Chronic kidney disease is debilitating for many cats and significantly lessens their quality of life" - Silke Salavati, senior lecturer in Small Animal Internal Medicine.
Study will investigate three products designed to be added to food. 

Researchers at The University of Edinburgh's Royal (Dick) School of Veterinary Studies are researching the effect of therapies created to alleviate chronic kidney disease in cats.

Aiming to help limit the debilitating impact of chronic kidney disease in cats, the researchers will investigate ways to prevent toxins that develop in the gut of cats with kidney disease from entering the bloodstream.

Three products which are designed to be added to food will be investigated. One is a probiotic supplement aimed at limiting the formation of gut toxins, and the other two comprise small carbon particles designed to bind to toxins in the gut. 

“Simple interventions to bind toxins that originate in the guts of cats affected by chronic kidney disease, to limit the progress of the condition, may offer a viable route to alleviating the impact of the disease in millions of cats,” said Marina Domingues, resident in Small Animal Internal Medicine at Edinburgh's School of Veterinary Studies. 

A small group of healthy cats will be studied first, receiving each treatment in turn, and will then be monitored for effects on health and behaviour – while urine and faecal samples will be analysed to check for changes in gut microorganism composition changes. 

The second part of the study will see cats with chronic kidney disease studied, with owners given the option to administer one of the three products to their cat's food. All cats will be monitored for adverse effects, including urine and faecal testing. 

Supported by the Fiona and Ian Russell Seed Corn Fund, and the Clinical Study Fund of the European College of Veterinary Internal Medicine, the study hopes to demonstrate whether the treatments are effective. 

 

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.